Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab in First Line Metastatic Non-squamous Non-small Cell Lung Cancer Subjects.
Phase: 3Phase III in Spain, 2Phase II in Spain, 1Phase I in Spain